[Comparative efficacy of prodigiozan and proper-myl action on parameters of neutrophil phagocytosis in acute myeloblastic leukemia].
Guseva
S A
SA
Bal'shin
M D
MD
D000917:Antibody Formation / Q000187:drug effects; D001688:Biological Products / Q000494:pharmacology*; D004338:Drug Combinations; D007113:Immunity, Innate / Q000187:drug effects* / Q000276:immunology; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000276:immunology; D009504:Neutrophils / Q000187:drug effects* / Q000276:immunology; D010587:Phagocytosis / Q000187:drug effects*; D011354:Prodigiozan / Q000494:pharmacology*; D015002:Yeast, Dried / Q000494:pharmacology*
D001688:Biological Products; D004338:Drug Combinations; C003221:proper-myl; D011354:Prodigiozan
Sravnitel'naia éffektivnost' vliianiia prodigiozana i proper-mila na pokazateli neĭtrofil'nogo fagotsitoza pri ostrom mieloblastnom leĭkoze.